Effects of Racial Congruence, "Likes", and Food Images in Social Media Ads on Adolescents' Caloric Intake - Study 3

NCT06969651 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2026-04-01

No results posted yet for this study

Summary

This is a randomized trial to to test the degree to which visual attention to unhealthy foods, racially congruent people, and/or "likes" in social media ads explains the relationship between ad exposure and calorie intake.

Conditions

  • Calorie Consumption

Interventions

BEHAVIORAL

Black-Food

Ads featuring a Black person with a food product

BEHAVIORAL

White-Food

Ads featuring a White person with a food product

BEHAVIORAL

Black-Non Food

Ads featuring a Black person with a non-food product

BEHAVIORAL

White-Non Food

Ads featuring a White person with a non-food product

BEHAVIORAL

Food-Many Likes

Ads with Many "likes" featuring a food product

BEHAVIORAL

Non Food-Many Likes

Ads with Many "likes" featuring a non-food product

BEHAVIORAL

Food-Few Likes

Ads with Few "likes" featuring a food product

BEHAVIORAL

Non Food-Few

Ads with Few "likes" featuring a non-food product

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • National Cancer Institute (NCI)

    collaborator NIH
  • New York University

    collaborator OTHER
  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Marie A. Bragg, PhD · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06969651 on ClinicalTrials.gov